Cargando…

PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy

The reactivation of human JC polyoma virus (JCPyV) results in lytic infection of oligodendrocytes and neuronal cells. The corresponding clinical picture is called progressive multifocal leukoencephalopathy (PML) and results mostly from a disease-related or drug-induced immunosuppression. The opportu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möhn, Nora, Wattjes, Mike P., Adams, Ortwin, Nay, Sandra, Tkachenko, Daria, Salge, Friederike, Heine, Johanne, Pars, Kaweh, Höglinger, Günter, Respondek, Gesine, Stangel, Martin, Skripuletz, Thomas, Jacobs, Roland, Sühs, Kurt-Wolfram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129640/ https://www.ncbi.nlm.nih.gov/pubmed/34035834 http://dx.doi.org/10.1177/1756286421993684

Ejemplares similares

Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy
por: Hopfner, Franziska, et al.
Publicado: (2021)

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2022)

Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy
por: Luo, Yi, et al.
Publicado: (2020)

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2019)

Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2016)

Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2020)

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
por: Möhn, Nora, et al.
Publicado: (2020)

Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients
por: PUL, REFIK, et al.
Publicado: (2016)

Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?
por: Pul, Refik, et al.
Publicado: (2016)

Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization
por: Schwenkenbecher, Philipp, et al.
Publicado: (2017)

Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
por: Küpper, Clemens, et al.
Publicado: (2019)

Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021)

Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy
por: Mahler, Christoph, et al.
Publicado: (2020)

Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab
por: Boesl, Fabian, et al.
Publicado: (2022)

Varicella zoster virus infections in neurological patients: a clinical study
por: Skripuletz, Thomas, et al.
Publicado: (2018)

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab
por: Möhn, Nora, et al.
Publicado: (2019)

Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV
por: Pinnetti, Carmela, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in B-CLL Successfully Treated With Venetoclax and Pembrolizumab
por: Olivieri, Jacopo, et al.
Publicado: (2022)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
por: Boumaza, Xavier, et al.
Publicado: (2022)

Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway
por: Luo, Yi, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes
por: Pars, Kaweh, et al.
Publicado: (2019)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)

Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report
por: Stögbauer, Jakob, et al.
Publicado: (2020)

Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia
por: Kronenberg, Jessica, et al.
Publicado: (2019)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

Combined Treatment With Pembrolizumab and Allogenic BK Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Case Report
por: Wicklein, Rebecca, et al.
Publicado: (2021)

Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
por: Volk, Timo, et al.
Publicado: (2021)

Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review
por: Chatterjee, Tulika, et al.
Publicado: (2022)

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report
por: Mackenzie, Strachan, et al.
Publicado: (2021)

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
por: Dahlhaus, Stefanie, et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia
por: de Regt, Marieke J. A., et al.
Publicado: (2016)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
por: van der Kolk, Nicolien M., et al.
Publicado: (2016)

Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in the absence of immunosuppression
por: Zucker, Benjamin E., et al.
Publicado: (2017)

Progressive Multifocal Leukoencephalopathy: Current Insights
por: Kartau, Marge, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5il470blrq8elnbassv4fhnjse